What question did this study set out to answer?

The research aims to analyze the genomic characteristics of non-small cell lung cancer (NSCLC) with a focus on brain metastasis.

Genomic Analysis and Clinical Correlation of Non-Small Cell Lung Cancer with Special Reference to Brain Metastasis

View Full Paper

Ask AI

Bookmark

Authors

Genomic analysis reveals higher biomarker enrichment in non-small cell lung cancer with brain metastasis, indicating poorer outcomes.

The research aims to analyze the genomic characteristics of non-small cell lung cancer (NSCLC) with a focus on brain metastasis.
Conducted genomic analysis of NSCLC samples
Compared biomarker enrichment between NSCLC with and without brain metastasis
Identified targetable mutations in NSCLC-BM and mNSCLC
NSCLC-BM had a higher genomic biomarker enrichment (80%) compared to mNSCLC (68.68%)
EGFR was the predominant targetable mutation in NSCLC-BM
ALK mutations were also common in NSCLC-BM, while KRAS was primarily found in mNSCLC

Rudresha et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark